Australia Women's Health Market Size & Outlook, 2026-2033
Related Markets
Australia women's health market highlights
- The Australia women's health market generated a revenue of USD 1,137.0 million in 2025 and is expected to reach USD 1,907.0 million by 2033.
- The Australia market is expected to grow at a CAGR of 6.4% from 2026 to 2033.
- In terms of segment, contraceptives was the largest revenue generating application in 2025.
- Menopause is the most lucrative application segment registering the fastest growth during the forecast period.
Women's health market data book summary
| Market revenue in 2025 | USD 1,137.0 million |
| Market revenue in 2033 | USD 1,907.0 million |
| Growth rate | 6.4% (CAGR from 2026 to 2033) |
| Largest segment | Contraceptives |
| Fastest growing segment | Menopause |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, Australia accounted for 2.1% of the global women's health market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan women's health market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,721.0 million by 2033.
Contraceptives was the largest segment with a revenue share of 30.17% in 2025. Horizon Databook has segmented the Australia women's health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2021 to 2033.
According to the Fertility Society of Australia and New Zealand, every sixth couple has trouble becoming pregnant. Problems with fertility can be brought on by illnesses and other conditions. Overall, female reproductive difficulties account for one-third of infertility cases.
Such factors are expected to boost market growth. Moreover, players in the country are adopting various strategies to expand their market presence and meet consumer demand. For instance, in July 2022, Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA announced the availability of NEXTSTELLIS, an oral contraceptive with a novel estrogen in Australia.
Similarly, in October 2021, Slinda, a contraceptive pill manufactured by Exeltis, became available in Australia. Moreover, favorable initiatives undertaken by government bodies to consume contraceptive pills are expected to drive the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women's Health Market Scope
Women's Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Apothecus | View profile | 11-50 | Hicksville, New York, United States, North America | https://apothecus.com |
| Blairex Laboratories | View profile | 101-250 | Columbus, Indiana, United States, North America | http://www.blairex.com |
| Agile Therapeutics Inc | View profile | 19 | 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 | https://www.agiletherapeutics.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Australia women's health market size, by application, 2021-2033 (US$M)
Australia Women's Health Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
